344 related articles for article (PubMed ID: 33647280)
1. Squalene Epoxidase Induces Nonalcoholic Steatohepatitis Via Binding to Carbonic Anhydrase III and is a Therapeutic Target.
Liu D; Wong CC; Zhou Y; Li C; Chen H; Ji F; Go MYY; Wang F; Su H; Wei H; Cai Z; Wong N; Wong VWS; Yu J
Gastroenterology; 2021 Jun; 160(7):2467-2482.e3. PubMed ID: 33647280
[TBL] [Abstract][Full Text] [Related]
2. Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target.
Liu D; Wong CC; Fu L; Chen H; Zhao L; Li C; Zhou Y; Zhang Y; Xu W; Yang Y; Wu B; Cheng G; Lai PB; Wong N; Sung JJY; Yu J
Sci Transl Med; 2018 Apr; 10(437):. PubMed ID: 29669855
[TBL] [Abstract][Full Text] [Related]
3. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.
Simon Y; Kessler SM; Gemperlein K; Bohle RM; Müller R; Haybaeck J; Kiemer AK
World J Gastroenterol; 2014 Dec; 20(47):17839-50. PubMed ID: 25548482
[TBL] [Abstract][Full Text] [Related]
4. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
[TBL] [Abstract][Full Text] [Related]
5. The hepatocyte IKK:NF-κB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis.
Heida A; Gruben N; Catrysse L; Koehorst M; Koster M; Kloosterhuis NJ; Gerding A; Havinga R; Bloks VW; Bongiovanni L; Wolters JC; van Dijk T; van Loo G; de Bruin A; Kuipers F; Koonen DPY; van de Sluis B
Mol Metab; 2021 Dec; 54():101349. PubMed ID: 34626855
[TBL] [Abstract][Full Text] [Related]
6. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
[No Abstract] [Full Text] [Related]
8. Sesamin ameliorates nonalcoholic hepatic steatosis by inhibiting CD36-mediated hepatocyte lipid accumulation in vitro and in vivo.
Bai YP; Zhang T; Hu ZY; Zhang Y; Wang DG; Zhou MY; Zhang Y; Zhang F; Kong X
Biochem Pharmacol; 2024 Jun; 224():116240. PubMed ID: 38679210
[TBL] [Abstract][Full Text] [Related]
9. Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis.
Zhang M; Zhao Y; Li Z; Wang C
Biochem Biophys Res Commun; 2018 Jan; 495(1):582-586. PubMed ID: 29128353
[TBL] [Abstract][Full Text] [Related]
10. The L-α-Lysophosphatidylinositol/G Protein-Coupled Receptor 55 System Induces the Development of Nonalcoholic Steatosis and Steatohepatitis.
Fondevila MF; Fernandez U; Gonzalez-Rellan MJ; Da Silva Lima N; Buque X; Gonzalez-Rodriguez A; Alonso C; Iruarrizaga-Lejarreta M; Delgado TC; Varela-Rey M; Senra A; Garcia-Outeiral V; Novoa E; Iglesias C; Porteiro B; Beiroa D; Folgueira C; Tojo M; Torres JL; Hernández-Cosido L; Blanco Ó; Arab JP; Barrera F; Guallar D; Fidalgo M; López M; Dieguez C; Marcos M; Martinez-Chantar ML; Arrese M; Garcia-Monzon C; Mato JM; Aspichueta P; Nogueiras R
Hepatology; 2021 Feb; 73(2):606-624. PubMed ID: 32329085
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Effect of Gypenosides on Nonalcoholic Steatohepatitis via Regulating Hepatic Lipogenesis and Fatty Acid Oxidation.
Li H; Ying H; Hu A; Hu Y; Li D
Biol Pharm Bull; 2017; 40(5):650-657. PubMed ID: 28458350
[TBL] [Abstract][Full Text] [Related]
12. Discovery of an insulin-induced gene binding compound that ameliorates nonalcoholic steatohepatitis by inhibiting sterol regulatory element-binding protein-mediated lipogenesis.
Jiang SY; Yang X; Yang Z; Li JW; Xu MQ; Qu YX; Tang JJ; Li YF; Wang L; Shao YW; Meng XY; Hu H; Song BL; Rao Y; Qi W
Hepatology; 2022 Nov; 76(5):1466-1481. PubMed ID: 35102596
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice.
Yamamoto T; Nakade Y; Yamauchi T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sato K; Fukuzawa Y; Yoneda M
World J Gastroenterol; 2016 Feb; 22(8):2512-23. PubMed ID: 26937139
[TBL] [Abstract][Full Text] [Related]
14. Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression.
Azzu V; Vacca M; Kamzolas I; Hall Z; Leslie J; Carobbio S; Virtue S; Davies SE; Lukasik A; Dale M; Bohlooly-Y M; Acharjee A; Lindén D; Bidault G; Petsalaki E; Griffin JL; Oakley F; Allison MED; Vidal-Puig A
Mol Metab; 2021 Jun; 48():101210. PubMed ID: 33722690
[TBL] [Abstract][Full Text] [Related]
15. Folate receptor-beta expression as a diagnostic target in human & rodent nonalcoholic steatohepatitis.
Lake AD; Hardwick RN; Leamon CP; Low PS; Cherrington NJ
Toxicol Appl Pharmacol; 2019 Apr; 368():49-54. PubMed ID: 30794826
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte-specific clusterin overexpression attenuates diet-induced nonalcoholic steatohepatitis.
Park JS; Shim YJ; Kang BH; Lee WK; Min BH
Biochem Biophys Res Commun; 2018 Jan; 495(2):1775-1781. PubMed ID: 29229391
[TBL] [Abstract][Full Text] [Related]
17. Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis.
Li C; Wang Y; Liu D; Wong CC; Coker OO; Zhang X; Liu C; Zhou Y; Liu Y; Kang W; To KF; Sung JJ; Yu J
Gut; 2022 Nov; 71(11):2253-2265. PubMed ID: 35232776
[TBL] [Abstract][Full Text] [Related]
18. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.
Zhang X; Fan L; Wu J; Xu H; Leung WY; Fu K; Wu J; Liu K; Man K; Yang X; Han J; Ren J; Yu J
J Hepatol; 2019 Jul; 71(1):163-174. PubMed ID: 30914267
[TBL] [Abstract][Full Text] [Related]
19. Reduction of Squalene Epoxidase by Cholesterol Accumulation Accelerates Colorectal Cancer Progression and Metastasis.
Jun SY; Brown AJ; Chua NK; Yoon JY; Lee JJ; Yang JO; Jang I; Jeon SJ; Choi TI; Kim CH; Kim NS
Gastroenterology; 2021 Mar; 160(4):1194-1207.e28. PubMed ID: 32946903
[TBL] [Abstract][Full Text] [Related]
20. Targeting squalene epoxidase restores anti-PD-1 efficacy in metabolic dysfunction-associated steatohepatitis-induced hepatocellular carcinoma.
Wen J; Zhang X; Wong CC; Zhang Y; Pan Y; Zhou Y; Cheung AH; Liu Y; Ji F; Kang X; Liu D; Yu J
Gut; 2024 May; ():. PubMed ID: 38744443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]